Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Diffusely infiltrating malignant astrocytoma with anaplasia, marked proliferative potential
Infiltrating mass that predominately involves white matter with variable enhancement
T2 heterogeneously hyperintense
Neoplastic cells almost always found beyond areas of abnormal signal intensity
May involve and expand overlying cortex
Usually no enhancement; focal, nodular, homogeneous, patchy enhancement less common
Ring enhancement is suspicious for glioblastoma (GBM)
MRS: Increased Cho/Cr ratio, decreased N -acetylaspartate
MRP: Elevated maximum regional cerebral blood volume
Anaplastic astrocytomas have histologic and imaging characteristics along spectrum between low-grade astrocytoma and GBM
Low-grade diffuse astrocytoma
GBM
Oligodendroglioma
Cerebritis
Ischemia
WHO grade III
Usually evolves from low-grade (diffuse) astrocytoma (WHO grade II) (75%)
Most common presentation: Marked clinical deterioration in patient with grade II astrocytoma
Occurs at all ages, most common 40-50 years; 1/3 of astrocytomas
Prognosis: Median survival: 2-3 years
IDH1 (+) and MGMT (+) associated with increased survival
IDH1, ATRX wild-type (not mutated) = poor prognosis
Anaplastic astrocytoma (AA)
Grade III astrocytoma, malignant astrocytoma, high-grade astrocytoma
Diffusely infiltrating malignant astrocytoma with focal or diffuse anaplasia and marked proliferative potential
Best diagnostic clue
Infiltrating mass that predominately involves white matter (WM) with variable enhancement
Location
Hemispheric WM
Commonly involves frontal and temporal lobes
May involve pons, thalamus (pons common in children)
Less commonly involves brainstem, spinal cord
Size
Variable
Morphology
Ill-defined hemispheric WM mass typical
May appear well circumscribed
Neoplastic cells almost always found beyond areas of abnormal signal intensity
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here